Our latest news

Anthony A. Hyman’s mandate to commence 31 March 2026 At its winter meeting, EMBL Council selected Anthony A. Hyman as EMBL’s next Director General.  “I am pleased to announce the decision by the EMBL Council to elect Anthony Hyman as future EMBL Director General,” said Peter Becker, EMBL Council Chair. “Tony witnessed the spirit of […]

Cambridge, UK, 20 November 2025: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, today announced a collaboration with Pacific Biosciences (PacBio), a pioneer in long-read sequencing, to automate PacBio’s Kinnex™ full-length RNA-seq library preparation on SPT Labtech’s firefly® liquid handling platform. The automated workflow will improve reproducibility […]

Ovesco Endoscopy AG from Tübingen is investing almost € 1 million in the company Trans-Duodenal Concepts GmbH, Mannheim, to jointly promote innovative solutions in the field of metabolic-bariatric endoscopy. Around one billion people worldwide are affected by metabolic syndrome and its manifestations such as obesity, diabetes, hypertension and fatty liver disease. The Mannheim-based start-up Trans-Duodenal […]

DFG grants around 35,6 million euros to extend two transregional consortia and one CRC Heidelberg University has been successful in the current approval round of the German Research Foundation (DFG) with three grant applications for major research consortia. In the life sciences and medicine, a Collaborative Research Centre working on the Wnt signaling pathway will […]

Jens Puschhof, junior research group leader at the German Cancer Research Center (DKFZ), receives the 2026 Research Award from the Peter and Traudl Engelhorn Foundation. The foundation honors the young scientist for his research on the influence of bacteria on the development and spread of cancer. Jens Puschhof is analyzing the close interactions between tumor […]

The TRANSCAN-3 project (T-PLEX EAC), funded by the European Union, is approaching the end of its second year with significant progress in developing personalized adoptive T cell therapies for patients with esophageal adenocarcinoma (EAC). EAC remains the most common esophageal cancer in Western populations, and despite advances in chemotherapy, radiotherapy, and surgery, only around 20% […]

New research suggests that inflammatory support cells play a key role in damaging bone marrow early in cancer development – potentially offering a new target for treatments that stop blood disorders before becoming cancerous. Summary The following news article is an amended version of a news release from UMC Mainz Office of Communications, published with […]

New Haven, CT, USA, November 25, 2025 – BioMed X, a leading external innovation hub for pharma, announced today the launch of a new collaborative research project with AbbVie, hosted at the BioMed X Institute in New Haven, Connecticut. The topic of the new research project in the field of neuroscience is the development of “Circuit-Based Model […]

EMBL-EBI receives UKRI Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR) funding for enhancing and translating mental-health omics data into the Open Targets Platform Summary Identifying targets for new treatments for mental health conditions could become faster, thanks to a new initiative that, for the first time, will bring patient […]